| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Experimental Cardiovascular Biology Research Unit, Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada. * To whom correspondence should be addressed. E-mail: christian.deschepper{at}ircm.qc.ca.
The Many Possible Benefits of Natriuretic Peptides After Myocardial Infarction
Christian F. Deschepper*
This article has been cited by other articles:
![]() |
A. K. Houng, R. A. McNamee, A. Kerner, P. Sharma, A. Mohamad, J. Tronolone, and G. L. Reed Atrial natriuretic peptide increases inflammation, infarct size, and mortality after experimental coronary occlusion Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H655 - H661. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Souzeau, B. Llamas, S. Belanger, S. Picard, and C. F. Deschepper A Genetic Locus Accentuates the Effect of Volume Overload on Adverse Left Ventricular Remodeling in Male and Female Rats Hypertension, January 1, 2006; 47(1): 128 - 133. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |